Abiomed Device Approved


Abiomed (NASDAQ: ABMD) has gained FDA approval for a new circulatory support device, the Danvers, MA-based company announced today. The device—a console that drives various balloons and pumps used in treating heart failure—is already approved in Europe.

By posting a comment, you agree to our terms and conditions.